Consalvo Mattia

Prof. Consalvo Mattia


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Bone Abstracts
Verified
Journal Article
Closed access
CMConsalvo Mattia
Consalvo Mattia
FCFlaminia Coluzzi
Flaminia Coluzzi
LCLudovica Celidonio
Ludovica Celidonio
RVRenato Vellucci
Renato Vellucci
Bone pain in elderly people dramatically affects their quality of life, with osteoporosis being the leading cause of skeletal related events. Peripheral and central mechanisms are involved in the pathogenesis of the nervous system sensitization. Osteoporosis in the elderly has been associated with increased density of bone sensory nerve fibers and their pathological modifications, together with an over-expression of nociceptors sensitized by the lowering pH due to the osteoclastic activity. The activation of N-methyl-D-aspartate (NMDA) receptors and the microglia, as a response to a range of pathological conditions, represent the leading cause of central sensitization. Unfortunately, osteoporosis is named the "silent thief" because it manifests with painful manifestation only when a fracture occurs. In the management of patients suffering from bone pain, both the nociceptive and the neuropathic component of chronic pain should be considered in the selection of the analgesic treatment.

1 August 2010
Verified
Journal Article
Closed access
GSG Savoia
G Savoia
DADaniela Alampi
Daniela Alampi
BAB Amantea
B Amantea
FAF Ambrosio
F Ambrosio
RAR Arcioni
R Arcioni
CMConsalvo Mattia
Consalvo Mattia

31 May 2021 in Biomolecules
Verified
Journal Article
Open access
PDF file
RIRosmara Infantino
Rosmara Infantino
CMConsalvo Mattia
Consalvo Mattia
PLPamela Locarini
Pamela Locarini
Antonio Luigi PastoreAntonio Luigi Pastore
Antonio Luigi Pastore
SMSabatino Maione
Sabatino Maione
Livio LuongoLivio Luongo
Livio Luongo
Chronic pain, including neuropathic pain, represents an untreated disease with important repercussions on the quality of life and huge costs on the national health system. It is well known that opioids are the most powerful analgesic drugs, but they represent the second or third line in neuropathic pain, that remain difficult to manage. Moreover, these drugs show several side effects that limit their use. In addition, opioids possess addictive properties that are associated with misuse and drug abuse. Among available opioids compounds, buprenorphine has been suggested advantageous for a series of clinical reasons, including the effectiveness in neuropathic pain. Some properties are partly explained by its unique pharmacological characteristics. However, questions on the dynamic profile remain to be answered. Pharmacokinetics optimization strategies, and additional potentialities, are still to be explored. In this paper, we attempt to conceptualize the potential undiscovered dynamic profile of buprenorphine.

18 October 2012 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
CMConsalvo Mattia
Consalvo Mattia
EBEleonora Di Bussolo
Eleonora Di Bussolo
FCFlaminia Coluzzi
Flaminia Coluzzi
Opioid consumption is associated with a wide range of side effects. Potential interference of opioids with bone and joint activity has emerged in the last few years. Opioids increase the risk of fracture, especially in elderly patients. Moreover, opioids interfere with the endocrine system, and their chronic use is a recognized risk factor for osteoporosis. Pathogenetic mechanisms at the basis of the interference of opioids with bones and joints are analysed in this review.

22 May 2014
Verified
Journal Article
Closed access
GSG Savoia
G Savoia
Flaminia ColuzziFlaminia Coluzzi
Flaminia Coluzzi
CMC Di Maria
C Di Maria
FAF Ambrosio
F Ambrosio
FCFrancesco Della Corte
Francesco Della Corte
GRG Radeschi
G Radeschi

1 November 2003 in Mini-Reviews in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
CMConsalvo Mattia
Consalvo Mattia
FCFlaminia Coluzzi
Flaminia Coluzzi
This review presents available clinical studies and new insights into mechanisms of analgesic effect and possible new routes of administration of antidepressant drugs. Older TCAs continue to be superior treatments. We focused on recent findings on newer antidepressants as analgesics. Their use should be supported by further controlled trials.